WASHINGTON — The Food and Drug Administration has approved the first treatment for children with peanut allergies. Allergy experts say Aimmune Therapeutics' Palforzia promises to lower the chances ...

UNDATED (WKRC) - Richard Lassiter, a 44-year-old with a severe peanut allergy, can now eat peanuts daily after participating in a "life-changing" desensitization trial. The trial gradually exposed 18 ...

A large study provides the strongest evidence that children and teenagers can be desensitized to peanut allergies through controlled, escalating exposure to a substance that could otherwise trigger a ...

A real-world study from UVA Health Children's Hospital has shown that early peanut oral immunotherapy (epOIT) is safe and effective in desensitizing young children to peanuts. 27 children completed ...

Oral immunotherapy (pOIT) significantly increases peanut challenge tolerance in children compared to avoidance, with 74% success in the pOIT group versus 11% in the avoidance group. The study ...

Innovation is critical for success in the healthcare industry. A key step to that success is the evaluation of new therapies. Managers need to understand the commercial potential of ideas and invest ...

A man with a life-threatening peanut allergy is living a near-normal life after taking part in a “life-changing” study which gradually saw him exposed to nuts. Richard Lassiter’s allergy is so severe ...

The MarketWatch News Department was not involved in the creation of this content. Funding supports Mind Meld, FARE's research initiative designed to accelerate a cure for food allergy McLEAN, Va., Feb ...

A low-dose peanut oral immunotherapy (OIT) protocol using parent-measured dosing can desensitize children aged 1-4 years with peanut allergy. The approach appears to be acceptably safe and may yield ...

Aimmune Therapeutics is teaming with Regeneron Pharmaceuticals in hopes of developing a cure for peanut allergies. Aimmune, based in Brisbane, California, specializes in food allergy treatments and ...

Sofia was just a few months old when she suffered her first allergic reaction to peanuts. "I was eating peanut butter on toast," her mother Sam remembered. "She was sat in her high chair, she picked ...

JD Hayball is in receipt of research funding support from Sementis Ltd. PM Howley is Chief Scientific Officer, co-founder and a major shareholder of Sementis Ltd. The authors have no other relevant ...